A tetravalent dengue nanoparticle stimulates antibody production in mice

Journal of Nanobiotechnology

Volumn 10, Issue , 2012, Pages

  Silva, Elisângela F ^a   Orsi, Mariana ^a   Andrade, Ângela L ^b   Domingues, Rosana Z ^c   Silva, Breno M ^b   de Araújo, Helena R C ^d   Pimenta, Paulo F P ^d   Diamond, Michael S ^e   Rocha, Eliseu S O ^c   Kroon, Erna G ^c   Malaquias, Luiz C C ^a   Coelho, Luiz F L ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Humoral response; Inactivated dengue v rus; Nanoparticles

Indexed keywords

ANTI-VIRAL DRUGS; ANTIBODY PRODUCTION; BIODEGRADABLE NANOPARTICLE; BOVINE SERUM ALBUMINS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FUNCTIONAL ACTIVITIES; HUMORAL RESPONSE; IMMUNOGENICITY; IN-VIVO; MURINE MODEL; NANOPARTICLE SYSTEMS; SEROTYPES; SUBTROPICAL REGIONS;

ANTIGENS; MAMMALS; NANOPARTICLES; VACCINES; VIRUSES;

ANTIBODIES;

BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NANOPARTICLE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE MODEL; HUMAN; HUMORAL IMMUNITY; IN VIVO STUDY; MOUSE; NONHUMAN; SEROTYPE; VIRUS INACTIVATION; ANIMAL; BIOSYNTHESIS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; SCANNING ELECTRON MICROSCOPY; SERODIAGNOSIS; VIRUS CULTURE;

BOVINAE; DENGUE VIRUS; MURINAE; MUS;

ANIMALS; ANTIBODIES, VIRAL; DENGUE VIRUS; MICE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NEUTRALIZATION TESTS; VIRAL PLAQUE ASSAY;

EID: 84858716805     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-10-13     Document Type: Article

References (23)

1. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008, 371:500-509.
2. Kyle JL, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol 2008, 62:71-92.
3. Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 2011, 29:587-619.
4. Murrell S, Wu SC, Butler M. Review of dengue virus and the development of a vaccine. Biotechnol Adv 2011, 29:239-47.
5. Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA. Polymeric particles in vaccine delivery. Curr Opin Microbiol 2010, 13:106-112.
6. Klippstein R, Pozo D. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine 2010, 6:523-529.
7. Ferreira GP, Figueiredo LB, Coelho LF, S PA, Cecilio AB, Ferreira PC, Bonjardim CA, Arantes RM, Campos MA, Kroon EG. Dengue virus 3 clinical isolates show different patterns of virulence in experimental mice infection. Microbes Infect 2010, 12:546-54.
8. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, Chin KC, Aw P, George J, Kuznetsov VA, Schreiber M, Vasudevan SG, Hibberd ML. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 2007, 1:e86.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-54.
10. Brien JD, Austin SK, Sukupolvi-Petty S, O'Brien KM, Johnson S, Fremont DH, Diamond MS. Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol 2010, 84:10630-43.
11. Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS. Structure and function analysis of therapeutic monoclonal Antibodies against dengue virus type 2. J Virol 2010, 84:9227-39.
12. Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, O'Brien KM, Nelson CA, Johnson S, Fremont DH, Diamond MS. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog 2010, 6:e1000823.
13. Stephenson JR. Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 2005, 83:308-314.
14. Krone B, Lenz A, Heermann KH, Seifer M, Lu XY, Gerlich WH. Interaction between hepatitis B surface proteins and monomeric human serum albumin. Hepatology 1990, 11:1050-1056.
15. de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 2011, 5:e1188.
16. Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J 2010, 4:7-28.
17. Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, Rey FA, Varani L, Whitehead SS, Diamond MS, Harris E, Lanzavecchia A, Sallusto F. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010, 8:271-83.
18. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328:745-8.
19. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of theFlavivirus life cycle. Nat Rev Microbiol 2005, 3:13-22.
20. Miller JL, de Wet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, Gordon S. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 2008, 4:e17.
21. Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier JL, Rey FA, Despres P, Arenzana-Seisdedos F, Amara A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem 2005, 280:23698-23708.
22. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, Libraty DH. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 2006, 177:7114-7121.
23. Geeraedts F, Goutagny N, Hornung V, Severa M, de Haan A, Pool J, Wilschut J, Fitzgerald KA, Huckriede A. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog 2008, 29:e1000138.